A randomised controlled trial of fMRI-neurofeedback in depressio
- Conditions
- Affective DisorderDepression10027946
- Registration Number
- NL-OMON54250
- Lead Sponsor
- niversiteit Maastricht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 120
1. Diagnosis of a depressive disorder (ICD-10: F32 or F33)
2. Has been on stable antidepressant medication (single or combination
treat-ment) for at least 4 weeks
3. Currently depression (QIDS >= 17)
4. If required to meet recruitment targets the minimum entry score will be
reduced QIDS >= 13 (i.e. still corresponding to a moderate level of depression)
1. Exclusion criteria for MRI (e.g. cardiac pacemaker, certain metallic
implants)
2. History of psychotic disorder bipolar disorder, or psychotic depression
3. Current use of illegal drugs (any in the last four weeks)
4. Current excessive alcohol consumption that interferes with daily functioning
5. History of neurological disease that could influence the fMRI signal and/or
the ana-tomical alignment (e.g. territorial stroke, multiple sclerosis, brain
tumour)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>IDS (Inventory of Depressive Symptomatology) scores at post-intervention<br /><br>between groups</p><br>
- Secondary Outcome Measures
Name Time Method <p>1. Scores at post-intervention between groups for:<br /><br><br /><br>BDI (Beck Depression Inventory)<br /><br>HADS (Hospital Anxiety and Depression Scale)<br /><br>SES (Self Efficacy Scale)<br /><br>QoL (Quality Of Life scale)<br /><br>EQ-5D-5L (EuroQol research foundation questionnaire)<br /><br>PsyMate depression questions<br /><br><br /><br>2. Scores after each neurofeedback session in<br /><br>Profile of Mood States (POMS)<br /><br><br /><br>3. Neurofeedback performance<br /><br><br /><br>4. Changes in brain structure / activation over time<br /><br><br /><br>5. Correlations between neurofeedback performance and the other measures at<br /><br>baseline, during the training and post intervention </p><br>